Data Composite

Dopamine Hydrochloride Injection Shortage

11 of 11 tracked records currently active across 3 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Hospira, Inc., a Pfizer Company DOPAMINE HYDROCHLORIDE IN DEXTROSE Current 09/09/2026
Hospira, Inc., a Pfizer Company Current 09/09/2026
Hospira, Inc., a Pfizer Company DOPAMINE HYDROCHLORIDE IN DEXTROSE Current 09/09/2026
Hospira, Inc., a Pfizer Company DOPAMINE HYDROCHLORIDE Current 09/09/2026
Baxter Healthcare DOPAMINE HYDROCHLORIDE AND DEXTROSE Current 09/04/2026
Baxter Healthcare DOPAMINE HYDROCHLORIDE AND DEXTROSE Current 09/04/2026
Baxter Healthcare DOPAMINE HYDROCHLORIDE AND DEXTROSE Current 09/04/2026
Baxter Healthcare DOPAMINE HYDROCHLORIDE AND DEXTROSE Current 09/04/2026
Hikma Pharmaceuticals USA, Inc. DOPAMINE HYDROCHLORIDE Current 09/03/2026
Hikma Pharmaceuticals USA, Inc. DOPAMINE HYDROCHLORIDE Current 09/03/2026
Hospira, Inc., a Pfizer Company DOPAMINE HYDROCHLORIDE Current 08/24/2026

← All shortages